Pacing-Induced Increase in QT Dispersion Predicts Sudden Cardiac Death Following Cardiac Resynchronization Therapy

Journal of the American College of Cardiology

Volumn 47, Issue 12, 2006, Pages 2486-2492

  Chalil, Shajil ^a   Yousef, Zaheer R ^a   Muyhaldeen, Sarkaw A ^a   Smith, Russell E A ^a   Jordan, Paul ^a   Gibbs, Christopher R ^a   Leyva, Francisco ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; SPIRONOLACTONE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REPOLARIZATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QRS COMPLEX; QT DISPERSION; QT INTERVAL; QT PROLONGATION; SUDDEN DEATH;

AGED; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROGNOSIS; RISK FACTORS;

EID: 33744984132     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.12.074     Document Type: Article

References (21)

1. Cleland J.G.F., Daubert J.-C., Erdmann E., et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1-11
2. Bradley D.J., Bradley E.A., Baughman K.L., et al. Cardiac resynchronization and death from progressive heart failure. a meta-analysis of randomized controlled trials. JAMA 289 (2003) 730-740
3. Medina-Ravell V.A., Lankipalli R.S., Yan G.-X., et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?. Circulation 107 (2003) 740-746
4. Yan G.X., and Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 98 (1998) 1928-1936
5. Fish J.M., Di Diego J.M., Nesterenko V., and Antzelevitch C. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization. Circulation 109 (2004) 2136-2142
6. Guyatt G.H., Sullivan M.J., and Thompson P.J. The 6-minute walk. a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
7. Rector T.S., Kubo S.H., and Cohn J.N. Patient's self-assessment of their congestive heart failure. Content, reliability and validity of a new measure-the Minnesota living with heart failure questionnaire. Heart Failure 3 (1987) 198-207
8. Myerburg R.J., and Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E. (Ed). Heart Disease. A Textbook of Cardiovascular Medicine (1997), WB Saunders Publishing Co, New York, NY 742-779
9. Ritter P., Padeletti L., Gillio-Meina L., and Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. comparison between echo and peak endocardial acceleration measurements. Europace 1 (1999) 126-130
10. Coumel P., Maison-Blanche P., and Badilini F. Dispersion of ventricular repolarization. Reality? Illusion? Significance?. Circulation 97 (1998) 2491-2493
11. Brendrop B., Elming H., Jun L., et al. QT dispersion has no prognostic information for patients with advanced congestive cardiac failure and reduced left ventricular systolic function. Circulation 103 (2001) 831-835
12. Bazett H.C. An analysis of time relations of the electrocardiogram. Heart 7 (1920) 353-370
13. Day C.P., McComb J.M., and Campbell R.W.F. QT dispersion. an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63 (1990) 342-344
14. Bristow M.R., Saxon L.A., Borehmer J., et al., Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Eng J Med 350 (2004) 2140-2150
15. de Bruyne M.C., Hoes A.W., Kors J.A., Hofman A., van Bremmel J.H., and Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam Study. Circulation 97 (1998) 467-472
16. Glancy J.M., Garrat C.J., Woods K.L., and de Bono D.P. QT dispersion and mortality after myocardial infarction. Lancet 345 (1995) 945-948
17. Barr C.S., Naas A., Freeman M., Lang C.C., and Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343 (1994) 327-329
18. Walker S., Levy T., Rex S., et al. Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 86 (2000) 231-233
19. Higgins S.L., Yong P., Sheck D., et al., Ventak CHF Investigators. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Col Cardiol 36 (2000) 824-827
20. Packer D.L., Munger T.M., Johnson S.B., and Cragun K.T. Mechanism of lethal proarrhythmic observed in the Cardiac Arrhythmia Suppression Trial. role of adrenergic modulation of drug binding. Pacing Clin Electrophysiol 20 (1997) 455-467
21. Berger T., Hanser F., Hintringer F., et al. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure. J Cardiovasc Electrophysiol 16 (2005) 611-617